SCOLR Pharma, Inc. 4
4 · SCOLR Pharma, Inc. · Filed Feb 6, 2007
Insider Transaction Report
Form 4
FASSIHI REZA
Director
Transactions
- Exercise/Conversion
Common Stock (right to buy)
2007-02-02+50,000→ 0 totalExercise: $1.05From: 2003-04-07Exp: 2013-04-06→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2007-02-02$1.05/sh+50,000$52,500→ 50,067 total
Footnotes (2)
- [F1]The option was exercisable as to one-sixth (1/6th) of the total shares at the end of the six month period following 04/07/2003, as to an additional one-sixth (1/6th) of the total shares at the end of the subsequent six month period, and as to an additional one-third (1/3rd) of the total shares at the end of each subsequent twelve month period.
- [F2]Not applicable.